Palogic Value Management’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273K Sell
1,516
-32
-2% -$6.36K 0.12% 155
2025
Q4
$336K Buy
1,548
+321
+26% +$70.3K 0.14% 134
2025
Q3
$315K Hold
1,227
0.13% 135
2025
Q2
$318K Buy
1,227
+78
+7% +$19.8K 0.13% 130
2025
Q1
$280K Buy
1,149
+83
+8% +$20.9K 0.12% 129
2024
Q4
$272K Buy
1,066
+12
+1% +$3.21K 0.1% 140
2024
Q3
$310K Sell
1,054
-29
-3% -$8.18K 0.11% 143
2024
Q2
$263K Buy
1,083
+21
+2% +$5.01K 0.11% 136
2024
Q1
$284K Buy
1,062
+9
+0.9% +$2.29K 0.12% 130
2023
Q4
$260K Buy
+1,053
New +$214K 0.12% 133
2023
Q3
Sell
-923
Closed -$217K 157
2023
Q2
$217K Buy
+923
New +$194K 0.1% 137

Other funds holding EFX

Palogic Value Management's EFX Position: Q1 2026 in Review

Palogic Value Management reduced its Equifax (EFX) stake by 2.1% in Q1 2026, selling an estimated $6.36K and leaving 1,516 shares worth $273K. The position accounts for 0.12% of the portfolio, ranked #155.

Palogic Value Management first reported a position in EFX in Q2 2023 and has held it in 11 quarters since. The position peaked at $336K in Q4 2025. 870 funds tracked by Wall St. Rank hold EFX as of Q1 2026.

  • Palogic Value Management held 1,516 shares of Equifax worth $273K as of Q1 2026.
  • Palogic Value Management sold 32 Equifax shares in Q1 2026, an estimated $6.36K.
  • Equifax made up 0.12% of Palogic Value Management's portfolio in Q1 2026, its #155 holding.
  • Palogic Value Management first reported a position in Equifax in Q2 2023 and has held it in 11 quarters since.
  • Palogic Value Management's Equifax position peaked at $336K in Q4 2025.
  • 870 funds tracked by Wall St. Rank held Equifax as of Q1 2026.

Based on Palogic Value Management's 13F filing for Q1 2026, filed 15 May 2026.